Skip to main navigation Skip to search Skip to main content

EMCDDA Case study 5 — Expanding HCV screening and hepatitis treatment and care for PWID to harm reduction centres

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

33 Downloads (Pure)

Fingerprint

Dive into the research topics of 'EMCDDA Case study 5 — Expanding HCV screening and hepatitis treatment and care for PWID to harm reduction centres'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry